Assessment of the association of baseline anti-CarbV and anti-MCV antibodies with response to treatment and radiographic progression in an RA population treated with either methotrexate or baricitinib: post-hoc analyses from RA-BEGIN

BACKGROUND: The development of autoantibodies in patients with rheumatoid arthritis (RA) has potential as a marker of treatment response. This analysis assessed the association of an autoantibody response to carbamylated vimentin (anti-CarbV) and to vimentin modified by citrullination (anti-MCV) wit...

Descripción completa

Detalles Bibliográficos
Autores principales: López-Romero, Pedro, Martinez-Gamboa, Lorena, Bang, Holger, de la Torre, Inmaculada, Holzkämper, Thorsten, Feist, Eugen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437063/
https://www.ncbi.nlm.nih.gov/pubmed/32811536
http://dx.doi.org/10.1186/s13075-020-02284-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437063/
https://www.ncbi.nlm.nih.gov/pubmed/32811536
http://dx.doi.org/10.1186/s13075-020-02284-y

Ejemplares similares